These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3579908)

  • 1. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity.
    Slomiany BL; Bilski J; Sarosiek J; Murty VL; Dworkin B; VanHorn K; Zielenski J; Slomiany A
    Biochem Biophys Res Commun; 1987 Apr; 144(1):307-14. PubMed ID: 3579908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study on the microbiology of Campylobacter pyloridis and gastric histopathology.
    Ren J; Pan BR; Li MF; Lu P; Yan PS; Miao JY; Dong Y; Luo WH
    Keio J Med; 1990 Jun; 39(2):112-6. PubMed ID: 2214500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for weakening of gastric mucus integrity by Campylobacter pylori.
    Sarosiek J; Slomiany A; Slomiany BL
    Scand J Gastroenterol; 1988 Jun; 23(5):585-90. PubMed ID: 3399831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol).
    Slomiany BL; Kasinathan C; Slomiany A
    Am J Gastroenterol; 1989 Oct; 84(10):1273-7. PubMed ID: 2801678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.
    Price AB; Levi J; Dolby JM; Dunscombe PL; Smith A; Clark J; Stephenson ML
    Gut; 1985 Nov; 26(11):1183-8. PubMed ID: 4065695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Campylobacter pyloridis and its relation to peptic ulcer and chronic gastritis].
    Saenko VF; Pustovit AA; Medvetskiĭ EB; Gorshevikova EV
    Klin Khir (1962); 1988; (8):51-5. PubMed ID: 3059039
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation of Campylobacter pyloridis to gastritis and peptic ulcer.
    Buck GE; Gourley WK; Lee WK; Subramanyam K; Latimer JM; DiNuzzo AR
    J Infect Dis; 1986 Apr; 153(4):664-9. PubMed ID: 3950448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter pylori, mucus, and peptic ulceration. A dynamic interaction.
    Ormand JA; Talley NJ
    J Clin Gastroenterol; 1989 Oct; 11(5):492-5. PubMed ID: 2794427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of Campylobacter pyloridis in the etiology and pathogenesis of peptic ulcer].
    Loginov AS; Lorie NIu; Il'chenko AA; Radbil' OS
    Ter Arkh; 1988; 60(11):141-4. PubMed ID: 3070803
    [No Abstract]   [Full Text] [Related]  

  • 11. Campylobacter pyloridis, gastritis, and peptic ulceration.
    Goodwin CS; Armstrong JA; Marshall BJ
    J Clin Pathol; 1986 Apr; 39(4):353-65. PubMed ID: 3517070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.
    Morris A; Nicholson G
    Am J Gastroenterol; 1987 Mar; 82(3):192-9. PubMed ID: 3826027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins.
    Naughton JA; Mariño K; Dolan B; Reid C; Gough R; Gallagher ME; Kilcoyne M; Gerlach JQ; Joshi L; Rudd P; Carrington S; Bourke B; Clyne M
    Infect Immun; 2013 Aug; 81(8):2838-50. PubMed ID: 23716616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campylobacter pylori in chronic gastritis].
    Maaroos KhI
    Ter Arkh; 1989; 61(2):35-7. PubMed ID: 2727918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter pyloridis-associated primary gastritis in children.
    Drumm B; O'Brien A; Cutz E; Sherman P
    Pediatrics; 1987 Aug; 80(2):192-5. PubMed ID: 3615089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipolytic activity of Campylobacter pylori: effect of sofalcone.
    Slomiany BL; Nishikawa H; Piotrowski J; Okazaki K; Slomiany A
    Digestion; 1989; 43(1-2):33-40. PubMed ID: 2806755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.
    Hazell SL; Lee A; Brady L; Hennessy W
    J Infect Dis; 1986 Apr; 153(4):658-63. PubMed ID: 3950447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter pyloridis gastritis: the past, the present, and speculations about the future.
    Graham DY; Klein PD
    Am J Gastroenterol; 1987 Apr; 82(4):283-6. PubMed ID: 3551584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Campylobacter pyloridis in peptic ulcer].
    Aruin LI; Smotrova IA; Il'chenko AA
    Arkh Patol; 1988; 50(2):13-8. PubMed ID: 3377694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter pyloridis in the upper gastrointestinal tract: a Brazilian study.
    Coelho LG; Das SS; Karim QN; Walker MM; Queiroz DM; Mendes EN; Lima Júnior GF; de Oliveira CA; Baron JH; Castro Lde P
    Arq Gastroenterol; 1987; 24(1):5-9. PubMed ID: 3450271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.